Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BioNeMo is a cloud service and framework for drug discovery that leverages AI, built on NVIDIA NeMo Megatron, which enables the training and deployment of large-scale biomolecular transformer models. This service features pre-trained large language models (LLMs) and offers comprehensive support for standard file formats related to proteins, DNA, RNA, and chemistry, including data loaders for SMILES molecular structures and FASTA sequences for amino acids and nucleotides. Additionally, users can download the BioNeMo framework for use on their own systems. Among the tools provided are ESM-1 and ProtT5, both transformer-based protein language models that facilitate the generation of learned embeddings for predicting protein structures and properties. Furthermore, the BioNeMo service will include OpenFold, an advanced deep learning model designed for predicting the 3D structures of novel protein sequences, enhancing its utility for researchers in the field. This comprehensive offering positions BioNeMo as a pivotal resource in modern drug discovery efforts.
Description
NVIDIA NeMo LLM offers a streamlined approach to personalizing and utilizing large language models that are built on a variety of frameworks. Developers are empowered to implement enterprise AI solutions utilizing NeMo LLM across both private and public cloud environments. They can access Megatron 530B, which is among the largest language models available, via the cloud API or through the LLM service for hands-on experimentation. Users can tailor their selections from a range of NVIDIA or community-supported models that align with their AI application needs. By utilizing prompt learning techniques, they can enhance the quality of responses in just minutes to hours by supplying targeted context for particular use cases. Moreover, the NeMo LLM Service and the cloud API allow users to harness the capabilities of NVIDIA Megatron 530B, ensuring they have access to cutting-edge language processing technology. Additionally, the platform supports models specifically designed for drug discovery, available through both the cloud API and the NVIDIA BioNeMo framework, further expanding the potential applications of this innovative service.
API Access
Has API
No
API Access
Has API
Yes
Integrations
NVIDIA AI Foundations
Yes
AI-Q NVIDIA Blueprint
No
Accenture AI Refinery
No
Evo 2
Yes
Globant Enterprise AI
No
Keenable
No
Linker Vision
No
NVIDIA AI Data Platform
No
NVIDIA Blueprints
No
NVIDIA Clara
Yes
Integrations
NVIDIA AI Foundations
Yes
AI-Q NVIDIA Blueprint
Yes
Accenture AI Refinery
Yes
Evo 2
No
Globant Enterprise AI
Yes
Keenable
Yes
Linker Vision
Yes
NVIDIA AI Data Platform
Yes
NVIDIA Blueprints
Yes
NVIDIA Clara
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
NVIDIA
Founded
1993
Country
United States
Website
www.nvidia.com/en-us/gpu-cloud/bionemo/
Vendor Details
Company Name
NVIDIA
Founded
1993
Country
United States
Website
www.nvidia.com/en-us/gpu-cloud/nemo-llm-service/